Your browser doesn't support javascript.
loading
Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma.
Tomiyama, Nami; Tasaki, Yoshihiko; Hamamoto, Shuzo; Sugiyama, Yosuke; Naiki, Taku; Etani, Toshiki; Taguchi, Kazumi; Matsuyama, Nayuka; Sue, Yasuhito; Mimura, Yoshihisa; Odagiri, Kunihiro; Noda, Yusuke; Aoki, Maria; Moritoki, Yoshinobu; Nozaki, Satoshi; Kurokawa, Satoshi; Okada, Atsushi; Kawai, Noriyasu; Furukawa-Hibi, Yoko; Yasui, Takahiro.
Afiliação
  • Tomiyama N; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Tasaki Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Hamamoto S; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Sugiyama Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Naiki T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Etani T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Taguchi K; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Matsuyama N; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Sue Y; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Mimura Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Odagiri K; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Noda Y; Department of Urology, Toyota Kosei Hospital, Toyota, Aichi, Japan.
  • Aoki M; Department of Urology, Nagoya East Medical Center, Nagoya, Aichi, Japan.
  • Moritoki Y; Department of Urology, Anjo Kosei Hospital, Anjo, Aichi, Japan.
  • Nozaki S; Department of Urology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
  • Kurokawa S; Department of Urology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
  • Okada A; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Kawai N; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Furukawa-Hibi Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Yasui T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Int J Urol ; 30(9): 754-761, 2023 09.
Article em En | MEDLINE | ID: mdl-37150513
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Urol Assunto da revista: UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Urol Assunto da revista: UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão